Poland· PL-100493468
Vitaminum B1 + B6 + B12 G.L. Pharma
A vitamin b1 in combination with vitamin b6 and/or vitamin b12 product containing benfothiaminum + pyridoxini hydrochloridum + cyanocobalaminum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Benfothiaminum + pyridoxini hydrochloridum + cyanocobalaminum is registered in 7 of 19 countries.
Countries holding a registration under ATC A11DB (vitamin b1 in combination with vitamin b6 and/or vitamin b12), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Benfothiaminum + pyridoxini hydrochloridum + cyanocobalaminum · ATC A11DB
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Benfothiaminum + Pyridoxini hydrochloridum + Cyanocobalaminum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- A11DB
- ATC class
- Vitamin B1 in combination with vitamin B6 and/or vitamin B12
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin09008732019063
- gtin09008732019056
- gtin09008732019070
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benfothiaminum + pyridoxini hydrochloridum + cyanocobalaminum in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Бевит Трио, Бенфоневровит
- Czechia · Milgamma N, Neuromultivit Neo
- Germany · Neuromultivit
- Estonia · Neuromultivit
- Hungary · Milgamma N, Neurogerlon Neo
- Lithuania · Fenglavit, Milgamma N
- Latvia · Fenglavit, Milgamma N
- Romania · Milgamma N, Neuromultivit Neuro
- Slovenia · Neuromultivit
- Slovakia · Milgamma N, Tiadel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f604f077-11b5-426c-a39c-e181452a11a2 GET /v1/drugs/f604f077-11b5-426c-a39c-e181452a11a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "40 mg + 74,1 mg + 0,25 mg",
"packaging": "09008732019063 ¦ Rp ¦ 165010\n20 tabl.\n09008732019056 ¦ Rp ¦ 165011\n50 tabl.\n09008732019070 ¦ Rp ¦ 165012\n100 tabl.",
"substance": "Benfothiaminum 40 mg + Pyridoxini hydrochloridum 90 mg + Cyanocobalaminum 0.25 mg",
"common_name": "Benfothiaminum + Pyridoxini hydrochloridum + Cyanocobalaminum",
"pl_product_id": "100493468",
"pozwolenie_nr": "29406",
"auth_procedure": "DCP",
"authorisation_validity": "2030-12-01"
}See everything about benfothiaminum + pyridoxini hydrochloridum + cyanocobalaminum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.